Class 2 recall-Sabril Tablest & Sachets

Sanofi UK is recalling the listed batches of Sabril tablets and Sabril granules as a precautionary measure due to the detection of traces of tiapride in the batches of the source material of manufacturer for vigabatrin.

MHRA drug alert date: 13th July 2023

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-aventis-pharma-limited-t-slash-a-sanofi-sabril-500-mg-film-coated-tablets-and-sabril-500-mg-granules-for-oral-solution-el-23-a-slash-25?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=94be4cc6-3f3c-4a30-93a1-c5282da420d6&utm_content=immediately

Further Information

For stock control enquiries please contact GB-CustomerServices@sanofi.com or via telephone: 0800 854 430. For more information or medical information at uk-medicalinformation@sanofi.com or via telephone: 0800 035 25 25.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.